Novozymes A/S
Please read the full announcement in the attached PDF
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Verkkokauppa.com Oyj17.11.2025 15:45:00 CET | Press release
Verkkokauppa.com Oyj - Managers' Transactions – Samuli Seppälä
Cosmos Health Inc.17.11.2025 15:15:00 CET | Press release
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
MicroEJ17.11.2025 15:00:00 CET | Press release
MicroEJ and Boon Logic Partner to Simplify Edge AI with Unsupervised Learning for All Embedded Devices
Novo Nordisk A/S17.11.2025 14:58:29 CET | Press release
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bitget Limited17.11.2025 14:57:00 CET | Press release
Bitget Legal Team Wins Multiple 2025 Honours from LexisNexis and Thomson Reuters Asian Legal Business
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom